Atp13a2 Deficiency Aggravates Astrocyte-Mediated Neuroinflammation via NLRP3 Inflammasome Activation

Area of Science:

• Neuroscience
• Cell Biology
• Immunology

Background:

• Mutations in the ATP13A2 (Park9) gene cause lysosomal dysfunction and neuronal death in Parkinson's disease (PD).
• The specific role of ATP13A2 in astrocyte biology and its regulation of neuroinflammation in PD remains largely uncharacterized.

Purpose of the Study:

• To investigate the function of ATP13A2 in astrocytes.
• To elucidate the mechanisms by which astrocyte ATP13A2 regulates lysosomal function and neuroinflammation in a PD model.

Main Methods:

• Primary mouse midbrain neurons and astrocytes were cultured.
• Cells were treated with 1-methyl-4-phenylpyridinium (MPP(+)) to model PD.
• ATP13A2 expression, lysosomal function, cathepsin B release, and NLRP3 inflammasome activation were assessed in astrocytes.

Main Results:

• Astrocytes express significant levels of ATP13A2.
• ATP13A2 deficiency in astrocytes led to heightened inflammation and exacerbated dopaminergic neuron damage following MPP(+) exposure.
• Lack of ATP13A2 increased lysosomal membrane permeabilization and cathepsin B release, activating the NLRP3 inflammasome and increasing IL-1β production.

Conclusions:

• ATP13A2 plays a critical role in maintaining astrocyte lysosomal function and suppressing neuroinflammation.
• Astrocyte ATP13A2 modulates neuroinflammation through the NLRP3 inflammasome pathway.
• This study reveals a direct link between astrocyte lysosomes and neuroinflammation in Parkinson's disease pathogenesis.